Endorsements

Important Safety and Prescribing Information

Home

Healthcare Professionals

Media Center



print page	book mark	email page

Medically endorsed

Ranked #1 in doctor satisfaction by Podiatrists and Surgeons in a survey of advanced wound therapies¹
Endorsed by the APMA

APMA SEAL OF APPROVAL

1. Base: Respondents used product in last 3 months, 193 Podiatrists and Surgeons.

Important Safety Information

REGRANEX Gel should not be used in patients with cancers at the site of application. In a safety study, patients treated with 3 or more tubes of REGRANEX Gel had an increased risk of death from cancer at locations in the body other than the ulcer. Talk to your doctor about risks of cancer and tell your doctor if you have or have had cancer.

In clinical studies, a small percentage of patients treated with REGRANEX Gel or placebo gel experienced rash near the wound. REGRANEX Gel should not be used by patients sensitive to any components of this product. Please click here to see the Full Prescribing Information for REGRANEX Gel.

© Systagenix Wound Management (US), Inc. 2008. All rights reserved.
This site is published by Systagenix Wound Management (US), Inc. which is solely responsible for its contents.
This site is intended for U.S. audiences only.
Last Updated: 26 September 2007